Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 2038-2059
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2038
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2038
Figure 4 MiR-490-3P attenuates the Warburg effect and inhibits colon cancer cell proliferation.
A: The effect of miR-490-3P mimics or inhibitor on miR-490-3P expression was analyzed through quantitative real-time polymerase chain reaction analysis; B and C: SW620 and HCT116 cells were transfected with miR-490-3P control or mimics or inhibitor for 48 h. Then glucose uptake and lactate production were measured. Scale bar: 100 μm; D: The viability of SW620 and HCT116 cells transfected with miR-490-3P mimetics or inhibitors was evaluated using the cell counting kit-8 detection method; E: 5-ethynyl-2’-deoxyuridine incorporation assays were performed in SW620 and HCT116 cells with miR-490-3P mimics or inhibitor. The percentage of proliferating cells (red fluorescence) to total cells (blue fluorescence) was calculated. Scale bar: 100 μm; F and G: Flow cytometry was performed to evaluate the effect of miR-490-3P mimics or inhibitor on the cell cycle distribution and apoptosis. aP < 0.05, bP < 0.01, cP < 0.001 vs mimics-NC group; dP < 0.05, eP < 0.01, fP < 0.001 vs inhibitor-NC group, n = 3. NC: Normal control.
- Citation: Wan XH, Jin GB, Yang Q, Hu JL, Liu ZL, Rao J, Wen C, Li PL, Yang XM, Huang B, Wang XZ. Novel miR-490-3p/hnRNPA1-b/PKM2 axis mediates the Warburg effect and proliferation of colon cancer cells via the PI3K/AKT pathway. World J Gastrointest Oncol 2024; 16(5): 2038-2059
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/2038.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.2038